The Claim
Daily oral administration of 600 mg of inositol hexaphosphate (IP6) twice daily for two weeks has no statistically significant effect on the urinary uric acid to creatinine ratio in adults with hyperuricemia.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 600 mg of inositol hexaphosphate twice a day for two weeks does not change the ratio of uric acid to creatinine in urine among adults with high uric acid levels.
See the scientific wording
Daily intake of 600 mg of inositol hexaphosphate (IP6) twice daily for two weeks does not significantly alter the urinary uric acid to creatinine ratio in hyperuricemic adults, indicating that reduced serum uric acid is not mediated by increased renal excretion.
When inositol hexaphosphate is taken by mouth, it binds to purines from food in the intestines, preventing them from being absorbed into the bloodstream. With fewer purines reaching the liver, less uric acid is made, so blood levels drop. The kidneys do not excrete more uric acid, so the drop comes only from reduced production.
What the research says
1 studyTaking IP6 for two weeks lowered uric acid in the blood, but the kidneys didn’t flush out more of it—so the drop must be because less uric acid was absorbed from food, not because it was cleared faster by the kidneys.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.